Search This Blog

Tuesday, October 27, 2026

AbbVie submits FDA BLA for etentamig to treat adults with relapsed or refractory multiple myeloma

  after positive Phase 3 CERVINO results

https://finviz.com/stock?t=ABBV&p=d

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)